The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Phage resistant Escherichia coli strains developed to reduce fermentation failure
Pharma & Human Health

Phage resistant Escherichia coli strains developed to reduce fermentation failure

AUG 25, 2022
Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes
Gastrointestinal

Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes

AUG 23, 2022
A focus on two critical needs for developing new products in the biotics industry
Pharma & Human Health

A focus on two critical needs for developing new products in the biotics industry

AUG 14, 2022
New needle-free nasal vaccine shows promise for COVID-19
Infectious Disease & AMR

New needle-free nasal vaccine shows promise for COVID-19

AUG 8, 2022
Expanding the range of foods that can improve health via the gut microbiome
Pharma & Human Health

Expanding the range of foods that can improve health via the gut microbiome

JUL 24, 2022
The retron switch
Pharma & Human Health

The retron switch

JUL 19, 2022
Machine learning begins to understand the human gut
Pharma & Human Health

Machine learning begins to understand the human gut

JUL 18, 2022
Enterome signs major strategic R&D collaboration with Nestlé Health Science
Finance

Enterome signs major strategic R&D collaboration with Nestlé Health Science

JUL 18, 2022
Seed Health and Axial Therapeutics Launch Gut-Brain Development Program
Finance

Seed Health and Axial Therapeutics Launch Gut-Brain Development Program

JUL 14, 2022
Researchers propose widespread banking of stool samples for fecal transplants later in life
Pharma & Human Health

Researchers propose widespread banking of stool samples for fecal transplants later in life

JUL 12, 2022
What to consider before launching a Direct-to-Consumer Microbiome Test
Pharma & Human Health

What to consider before launching a Direct-to-Consumer Microbiome Test

JUL 7, 2022